Item 7. Management’s Discussion and Analysis
Item 7. Management’s Discussion and Analysis
of Financial Condition and Results of Operations.
Cautionary Note Regarding Forward-Looking Statements
All statements other than
statements of historical fact included in this Report including, without limitation, statements under this Item regarding our financial
position, possible Business Combinations and the financing thereof, and related matters, and the plans and objectives of Management for
future operations, are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act. When used in this Report, words such as “may,” “should,” “could,” “would,” “anticipate,”
“believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us
or our Management, identify forward-looking statements. We have based these forward-looking statements on our Management’s current
expectations and projections about future events, as well as assumptions made by, and information currently available to, our Management.
Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed
in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf
are qualified in their entirety by this paragraph.
The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial
statements and the notes thereto included elsewhere in this Report.
Overview
We are a blank check company
incorporated in the Cayman Islands on February 21, 2024 for the purpose of effecting a Business Combination. Our Sponsor is Launch One
Sponsor LLC.
We are not limited in our
search for target businesses to a particular industry or sector for the purpose of consummating the Business Combination. We are an early
stage and emerging growth company and, as such, we are subject to all of the risks associated with early stage and emerging growth companies.
We expect to incur significant costs in the pursuit of our acquisition plans. There can be no assurance that our plans to complete a Business
Combination will be successful.
Our IPO Registration Statement
became effective on July 11, 2024. On July 15, 2024, we consummated our Initial Public Offering of 23,000,000 Units, including 3,000,000
Option Units issued pursuant to the full exercise of the Over-Allotment Option. Each Unit consists of one Public Share and one-half of
one Public Warrant. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to us of $230,000,000.
Simultaneously with the closing
of the Initial Public Offering and pursuant to the Private Placement Warrants Purchase Agreement, we completed the sale of an aggregate
of 6,000,000 Private Placement Warrants to the Sponsor and Cantor in the Private Placement at a purchase price of $1.00 per Private Placement
Warrant, generating gross proceeds to us of $6,000,000. Of those 6,000,000 Private Placement Warrants, the Sponsor purchased 4,000,000
Private Placement Warrants and Cantor purchased 2,000,000 Private Placement Warrants. The Private Placement Warrants are identical to
the Public Warrants, except as otherwise disclosed in the IPO Registration Statement.
Following the closing of the
Initial Public Offering and Private Placement, an amount of $230,000,000 from the net proceeds of the Initial Public Offering and the
Private Placement was initially placed in the Trust Account located in the United States with Continental acting as trustee. Pursuant
to the Trust Agreement, the Trust Account may be invested only (i) in U.S. government securities, within the meaning set forth in Section
2(a)(16) of the Investment Company Act with a maturity of 185 days or less, (ii) in any open-ended investment company that holds itself
out as a money market fund selected by us meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment
Company Act, (iii) as uninvested cash or (iv) in interest or non-interest bearing demand deposit accounts at a U.S. chartered commercial
bank with consolidated assets of $100 billion or more selected by the Trustee that is reasonably satisfactory to us, until the earlier
of: (x) the completion of the Business Combination and (y) the distribution of the Trust Account, as described below.
We have until July 15, 2026
(24 months from the closing of the Initial Public Offering), or until such (x) earlier date as our Board may approve or (y) later date
as our shareholders may approve, pursuant to the Amended and Restated Articles, to consummate the Business Combination. If we are unable
to complete the Business Combination by the end of the Combination Period, we will (i) cease all operations except for the purpose of
winding up, (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares, at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held
in the Trust Account and not previously released to us to pay taxes, if any, divided by the number of then outstanding Public Shares,
which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further
liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of our remaining shareholders and our Board, dissolve and liquidate, subject, in each case, to our obligations
under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
30
We may seek to extend the
Combination Period consistent with applicable laws, regulations and stock exchange rules by amending our Amended and Restated Articles.
Any such amendment would require the approval of our Public Shareholders, who will be provided the opportunity to redeem all or a portion
of their Public Shares in connection with the vote on such approval. Such redemptions will decrease the amount held in our Trust Account
and our capitalization, and may affect our ability to maintain our listing on Nasdaq. In addition, the Nasdaq Rules currently require
SPACs (such as us) to complete their initial Business Combination in accordance with the Nasdaq 36-Month Requirement. If we do not meet
the Nasdaq 36-Month Requirement, our securities will likely be subject to a suspension of trading and delisting from Nasdaq. Our Sponsor
may also, in its discretion, consider selling its interest in our Company to another sponsor entity, which may result in a change to our
Management Team.
Recent Developments
On June 25, 2025, we entered
into the Minovia BCA with the Minovia BCA Parties. As of January 30, 2026, we entered into the Minovia Termination Agreement with the
Minovia BCA Parties, pursuant to which the Minovia BCA Parties mutually agreed to terminate the Minovia BCA in its entirety pursuant to
Section 8.1(a) thereof. Concurrently with the termination of the Minovia BCA, each of the Ancillary Agreements (as defined in the Minovia
BCA) were automatically terminated. As a result, the Minovia BCA and Ancillary Agreements are of no further force and effect. In addition,
each party released the other parties from any and all liabilities and damages relating to the transaction documents, breaches thereunder
and the proposed transactions.
The foregoing summary of the
Minovia Termination Agreement is qualified in its entirety by the text of the Minovia Termination Agreement, a copy of which is attached
as Exhibit 10.11 hereto and is incorporated herein by reference.
We are seeking, with our Sponsor,
alternative ways to consummate an initial Business Combination.
On March 20, 2026, we entered
into a Working Capital Promissory Note (the “ Working Capital Note ”) with the Sponsor, pursuant to which the Sponsor
may loan up to $1,000,000 to us in up to three tranches in substantially the same amounts and on substantially the same terms as the loans
under that certain agreement, between the Sponsor and Keystone Capital Partners, LLC (“ Keystone ”), as agent for the
lenders party thereto (the “ Lenders ” and such agreement, the “ Credit Agreement ”), including an initial
loan to us of $500,000 upon execution and two additional loans of $250,000 each (in the case of the Working Capital Note, at the Sponsor’s
sole election) in the event that we (A) enter into a letter of intent, memorandum of understanding or other agreement with respect to
our Business Combination or (B) call a shareholder meeting to extend our deadline to consummate our initial Business Combination, (ii)
an original issue discount of 20% on each loan, such that the principal amount of each loan is 125% of the amount borrowed, (iii) annual
interest of 8%, with a default interest rate of an additional 18% (for a total of 26%), to the maximum extent permitted by applicable
law, (iv) a prepayment penalty of 10% (and in the case of the Working Capital Note, only to the extent with the written consent of the
Sponsor), (v) a maturity date for all such loans, interest and other obligations under the Working Capital Note of the consummation of
our initial Business Combination or the effective date of our winding up (or if earlier, upon an event of default), and (vi) an obligation
to reimburse the Sponsor for its expenses in connection with obtaining the funds for the initial loan under the Working Capital Note (up
to $25,000 to be withheld at the funding of the initial loan, which will be used to reimburse Keystone for its expenses under the Credit
Agreement) and for any expenses of the Sponsor in connection with any refinancing of the debt or the enforcement of the Working Capital
Note and for any reimbursement or indemnification obligations of the Sponsor under the Credit Agreement and related documents, subject
in each case to a cap of $20,000 per occurrence (other than with respect to indemnification obligations), which expense reimbursement
obligations will be taken out of the proceeds of any additional loans under the Working Capital Note or otherwise upon the maturity date
(or earlier event of default). In light of our limited cash balance at year end, our Board of Directors and Management determined to secure
additional working capital through the Working Capital Note to fund past and ongoing operational expenses.
In connection with the Working
Capital Note, the Sponsor entered into the Credit Agreement, pursuant to which the Lenders agreed to provide loans to the Sponsor of up
to $1,000,000 in the aggregate, to be funded in up to three tranches, consisting of an initial loan of $500,000 and two additional loans
of $250,000 each (with such additional tranches subject to the consent of Keystone, not to be unreasonably withheld, delayed or conditioned),
in each case subject to the terms and conditions of the Credit Agreement. In connection with the Credit Agreement, the Sponsor also entered
into a Pledge Agreement (the “ Pledge Agreement ”) with Keystone, pursuant to which the Sponsor pledged 2,932,500 Class
B Ordinary Shares (representing approximately 51% of the Founder Shares owned by the Sponsor), together with any proceeds thereof (the
“ Pledged Collateral ”), as collateral to secure the obligations under the Credit Agreement. The loans under the Credit
Agreement are non-recourse to the Sponsor, and the Lenders’ sole recourse in the event of a default is to foreclose upon such Pledged
Collateral, which would remain subject to the Company’s governing documents and applicable lock-up arrangements, including the terms
of the Letter Agreement. The Sponsor is required to use the proceeds of the loans under the Credit Agreement to fund loans to the Company
to pay for its expenses, including transaction expenses for future deals, amounts previously owed for prior business combination efforts
and for administrative expenses. The loans under the Credit Agreement mature upon the earlier of our initial Business Combination or the
Company’s liquidation. The Credit Agreement includes events of default for our failure to file with the SEC by a certain agreed
upon date a proxy statement to call for a shareholder meeting to extend our deadline to consummate an initial Business Combination or
for our failure to enter into a definitive Business Combination agreement with a target company or business prior to a certain agreed
upon date. However, the Credit Agreement and Pledge Agreement solely bind the Sponsor and do not restrict our actions.
31
Our Company, the Sponsor and
Cantor, also entered into a waiver letter pursuant to which the restrictions on transfers contained in the Letter Agreement were waived
solely to permit the pledge of the Pledged Collateral and any transfer thereof upon enforcement of the related security interest, but
with the Lenders taking such Pledged Collateral subject to the terms of the Letter Agreement.
Results of Operations
We have neither engaged in
any operations nor generated any revenues to date. Our only activities since February 21, 2024 (inception) through December 31, 2025 have
been (i) organizational activities and (ii) activities relating to (x) the Initial Public Offering and (y) identifying and evaluating
prospective acquisition candidates, such as Minovia, and activities in connection with the initial Business Combination. We will not generate
any operating revenues until after completion of our initial Business Combination. We have generated non-operating income in the form
of interest income on investments held in the Trust Account after the Initial Public Offering. We expect to incur increased expenses as
a result of being a public company (for legal, financial reporting, accounting and auditing compliance, among other things), as well as
for due diligence expenses.
For the year ended December
31, 2025, we had a net income of $8,309,154, which consisted of interest earned on cash and marketable securities held in the Trust Account
of $9,919,832 and interest earned on operating cash account of $403, partially offset by general and administrative costs of $1,611,081.
For the period from February
21, 2024 (inception) through December 31, 2024, we had a net income of $5,129,519, which consisted of interest earned on cash and marketable
securities held in the Trust Account of $5,404,164 and unrealized gain on marketable securities held in the Trust Account of $125,357,
offset by general and administrative costs of $400,002.
Liquidity, Capital Resources, and Going Concern
Following the Initial Public
Offering, including the full exercise of the Over-Allotment Option, and the Private Placement, a total of $230,000,000 was placed in the
Trust Account. We incurred $15,574,281 in transaction costs, consisting of $4,000,000 of cash underwriting fee, the Deferred Fee of $10,950,000
and $624,281 of other offering costs.
For the year ended December
31, 2025, cash used in operating activities was $820,192. Net income of $8,309,154 was affected by interest earned on cash and marketable
securities held in the Trust Account of $9,919,832. Changes in operating assets and liabilities provided $790,486 of cash for operating
activities.
For the period from February
21, 2024 (inception) through December 31, 2024, cash used in operating activities was $472,305. Net income of $5,129,519 was affected
by interest earned on marketable securities held in the Trust Account of $5,404,164, unrealized gain on marketable securities held in
Trust Account of $125,357 and payment of operation costs through the IPO Promissory Note of $50,736. Changes in operating assets and liabilities
used $123,039 of cash for operating activities.
As of December 31, 2025 and
December 31, 2024, we had marketable securities held in the Trust Account of $245,449,353 and $235,529,521, respectively (including $9,919,832
and $5,404,164 of interest income, respectively). We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use
substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (which
interest shall be net of taxes payable, if any, and exclude the Deferred Fee), to complete our Business Combination. To the extent that
our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds
held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions
and pursue our growth strategies.
To mitigate the risk that
we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold
investments in the Trust Account, we may, at any time, (based on our Management Team’s ongoing assessment of all factors related
to our potential status under the Investment Company Act) instruct the trustee to liquidate the investments held in the Trust Account
and instead to hold the funds in the Trust Account in cash or in an interest-bearing demand deposit account at a bank.
As of December 31, 2025 and
December 31, 2024, we had cash held outside of the Trust Account of approximately $30,146 and $850,338, respectively, and a working capital
deficit of $609,961 and a working capital of $947,121, respectively. We use the funds held outside the Trust Account primarily to identify
and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants,
or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements
of prospective target businesses, and structure, negotiate and complete a Business Combination.
32
Our liquidity needs through
December 31, 2025 have been satisfied through (i) a contribution of $25,000 from the Sponsor in exchange for the issuance of our Founder
Shares, (ii) a loan pursuant to the IPO Promissory Note, and (iii) the net proceeds from the consummation of the Initial Public Offering
and the Private Placement held outside the Trust Account.
IPO Promissory Note
Prior to the closing of our
Initial Public Offering, our Sponsor agreed to loan us an aggregate of up to $340,000 under the IPO Promissory Note to cover expenses
related to the Initial Public Offering. Such loans and advances were non-interest bearing and payable on the earlier of December 31, 2024
or the completion of our Initial Public Offering. We borrowed $307,974 under the IPO Promissory Note and $335,314 was paid to the Sponsor
upon the consummation of our Initial Public Offering on July 15, 2024, including an amount of $27,340 in excess of the outstanding IPO
Promissory Note balance. No additional borrowing is available under the IPO Promissory Note. The excess payment of $27,340 was due to
our Company as of December 31, 2025 and 2024.
Working Capital Loans
In order to fund working capital
deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors
or their affiliates may, but are not obligated to, loan us Working Capital Loans, as may be required. If we complete a Business Combination,
we will repay such Working Capital Loans. In the event that a Business Combination does not close, we may use a portion of the working
capital held outside the Trust Account to repay such Working Capital Loans, but no proceeds from our Trust Account would be used for such
repayment. Up to $1,500,000 of such Working Capital Loans may be converted into warrants of the post-Business Combination entity at a
price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Other than as set forth above, the terms
of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such Working Capital Loans.
As of December 31, 2025 and 2024, we did not have any borrowings under any Working Capital Loans.
Going Concern
In connection with our assessment
of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements—Going Concern”,
Management has determined that we currently lack the liquidity we need to sustain operations for a reasonable period of time, which is
considered to be at least one year from the date that the financial statements and the notes thereto included elsewhere in this Report
are issued, as we expect to continue to incur significant costs in pursuit of our acquisition plans. In addition, Management has determined
that if we are unable to complete an initial Business Combination within the Combination Period, then we will cease all operations except
for the purpose of liquidating. These conditions raise substantial doubt about our ability to continue as a going concern. Management
plans to consummate an initial Business Combination prior to the end of the Combination Period. No adjustments have been made to the carrying
amounts of assets or liabilities should we be required to liquidate after July 15, 2026. There can be no assurance that our plans to raise
capital or to consummate an initial Business Combination will be successful.
Contractual Obligations
We do not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities, other than as follows:
Administrative Services Agreement
Commencing
on July 11, 2024, and until the completion of our Business Combination or liquidation, we reimburse an affiliate of the Sponsor $12,500
per month for office space, utilities, and secretarial and administrative support pursuant to the Administrative Services Agreement. For
the year ended December 31, 2025, we incurred $150,000 in fees for these services, of which $62,500 is included in accrued expenses in
the balance sheets of the financial statements included elsewhere this Report. For the period from February 21, 2024 (inception) through
December 31, 2024, we incurred and paid $70,565 in fees for these services pursuant to the Administrative Services Agreement.
33
Underwriting Agreement
The Underwriters had a 45-day
option from the date of the Initial Public Offering to purchase up to an additional 3,000,000 Option Units to cover over-allotments,
if any. On July 15, 2024, simultaneously with the closing of the Initial Public Offering, the Underwriters elected to fully exercise the
Over-Allotment Option.
The Underwriters were entitled
to a cash underwriting discount of $4,000,000 (2.0% of the gross proceeds of the Units in the Initial Public Offering, excluding any proceeds
pursuant to the Over-Allotment Option). Additionally, the Underwriters are entitled to Deferred Fee of 4.50% of the gross proceeds of
the Initial Public Offering held in the Trust Account other than those sold pursuant to the Over-Allotment Option and 6.50% of the gross
proceeds sold pursuant to the Over-Allotment Option, which equals $10,950,000 in the aggregate, payable upon the completion of the initial
Business Combination subject to the terms of the Underwriting Agreement.
Registration Rights Agreement
The holders of (i) the Founder
Shares, (ii) the Private Placement Warrants and (iii) any private placement-equivalent warrants issued in connection with the Working
Capital Loans, if any (and in each case holders of their underlying securities, as applicable) are entitled to registration rights pursuant
to the Registration Rights Agreement, requiring us to register such securities for resale (in the case of the Founder Shares, only after
conversion to our Class A Ordinary Shares). The holders of the majority of these securities are entitled to make up to three demands,
excluding short form demands, that we register such securities. In addition, the holders have certain “piggyback” registration
rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require us
to register for resale such securities pursuant to Rule 415 under the Securities Act. Cantor may only make a demand on one occasion and
only during the five-year period beginning on the effective date of the IPO Registration Statement. In addition, Cantor may participate
in a “piggyback” registration only during the seven-year period beginning on the effective date of the IPO Registration Statement.
We will bear the expenses incurred in connection with the filing of any such registration statements.
Letter Agreement
Our Sponsor, directors and
officers have entered into the Letter Agreement with us, pursuant to which, they have waived their rights to liquidating distributions
from the Trust Account with respect to any Founder Shares held by them if we fail to complete our initial Business Combination within
the Combination Period. However, if they acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating
distributions from the Trust Account with respect to such Public Shares if we fail to complete our initial Business Combination within
the Combination Period.
Additionally, pursuant to
the Letter Agreement, our Sponsor, directors and officers will not propose any amendment to our Amended and Restated Articles to modify
(i) the substance or timing of our obligation to allow redemption in connection with our initial Business Combination or to redeem 100%
of our Public Shares if we do not complete our initial Business Combination within the Combination Period or (ii) any other material provisions
relating to shareholders’ rights or pre-initial Business Combination activity, unless we provide our Public Shareholders with the
opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released
to us to pay our taxes, divided by the number of then outstanding Public Shares.
Critical Accounting Estimates and Standards
The preparation of the financial
statements and notes thereto included elsewhere in this Report in conformity with GAAP requires Management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, income and expenses, and the disclosure of contingent assets and liabilities,
in our financial statements. These accounting estimates require the use of assumptions about matters, some of which are highly uncertain
at the time of estimation. Management bases its estimates on historical experience and on various other assumptions it believes to be
reasonable under the circumstances, the results of which form the basis for making judgments, and we evaluate these estimates on an ongoing
basis. To the extent actual experience differs from the assumptions used, our financial statements and notes thereto included elsewhere
in this Report could be materially affected. We believe that the following accounting policies involve a higher degree of judgment and
complexity. As of December 31, 2025, we did not have any critical accounting estimates to be disclosed.
34
Recent Accounting Standards
Management does not believe
that there are any recently issued, but not yet effective, accounting standards, which, if currently adopted, would have a material effect
on the financial statements and notes thereto included elsewhere in this Report.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.